🌍Stalecollected in 2h

Science Corp Preps First Human Brain Sensor Implant

Science Corp Preps First Human Brain Sensor Implant
PostLinkedIn
🌍Read original on The Next Web (TNW)
#bci#neurotech#human-trialsscience-corp-brain-sensor

💡Neuralink rival preps 520-electrode brain sensor for first human implant in 2027

⚡ 30-Second TL;DR

What Changed

Science Corp to implant first pea-sized 520-electrode brain sensor in human.

Why It Matters

This advances biological BCI alternatives to Neuralink's invasive electrodes, potentially enabling higher-resolution neural interfaces. Success could accelerate neurotech adoption in AI-driven prosthetics and cognition enhancement.

What To Do Next

Track Science Corp's 2027 trials for emerging BCI datasets in neuro-AI research.

Who should care:Researchers & Academics

🧠 Deep Insight

AI-generated analysis for this event.

🔑 Enhanced Key Takeaways

  • The sensor, known as the 'Science Eye' platform, utilizes a thin-film, high-density electrode array designed to sit on the surface of the visual cortex rather than penetrating the brain tissue.
  • Science Corp acquired the PRIMA retinal implant technology from Pixium Vision in 2024, integrating it into their broader neuro-technology portfolio.
  • The company's approach focuses on 'minimally invasive' neuro-engineering, aiming to avoid the risks associated with deep-brain electrode penetration used by some competitors.
📊 Competitor Analysis▸ Show
FeatureScience Corp (Brain Sensor)Neuralink (N1)Synchron (Stentrode)
Implantation MethodSurface (Non-penetrating)Penetrating (Threads)Endovascular (Blood vessel)
Electrode Count5201,02416
Primary TargetVisual CortexMotor CortexMotor Cortex
InvasivenessLow (Surface)High (Penetrating)Low (Endovascular)

🛠️ Technical Deep Dive

  • Sensor Architecture: Employs a high-density, flexible thin-film electrode array designed for surface-level neural signal acquisition.
  • Electrode Density: 520 electrodes configured for high-resolution mapping of the visual cortex.
  • Implantation Strategy: Designed for placement on the surface of the brain to minimize tissue damage and inflammatory response compared to penetrating arrays.
  • Data Processing: Utilizes proprietary ASIC (Application-Specific Integrated Circuit) technology for on-device signal processing and wireless data transmission.

🔮 Future ImplicationsAI analysis grounded in cited sources

Science Corp will achieve regulatory approval for human clinical trials by 2027.
The company's established history with the PRIMA system provides a regulatory roadmap and safety data that may accelerate the FDA approval process for their brain sensor.
Surface-level neural interfaces will become the industry standard for high-bandwidth BCI.
If successful, the non-penetrating nature of the Science Corp sensor offers a significantly safer risk-to-benefit profile than current penetrating electrode technologies.

Timeline

2021-01
Max Hodak departs Neuralink to found Science Corp.
2023-03
Science Corp raises $73 million in Series B funding to advance neuro-tech development.
2024-01
Science Corp acquires the assets and intellectual property of French company Pixium Vision, including the PRIMA system.
📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW)